15 Sep

Carevoyance

Share on FacebookTweet about this on TwitterShare on RedditPin on PinterestShare on LinkedInShare on Google+

At a Glance:

Carevoyance offers data-driven business applications that help life sciences companies with business development, market research and go-to-market strategy and execution.

In Depth:

Anatoly Geyfman, co-founder and CEO of Carevoyance, helped build the first HIPAA compliant benefit management and enrollment system while still in high school. Before starting Carevoyance, Geyfman was the Chief Architect of Ambra Health, where he built a platform to exchange medical images between physicians, hospitals and imaging clinics. Geyfman saw firsthand the regulatory hurdles in making this innovative technology more accessible. Thus, Geyfman wanted to make it easier for life science companies to navigate their products in such a restrictive environment by utilizing data, especially geospatial technologies.

Carevoyance is a sales enablement tool for life science organizations which include pharmaceutical companies, medical device companies, and anyone that provides necessary devices, drugs, tests and treatments for the care of patients. They help these companies sell more effectively, organize their territories more efficiently and point them to the right sales opportunity. Much of this relies on using geospatial technology analytics.

Life science companies can often be overwhelmed by the large number of physicians and healthcare organizations and it can be difficult for them to understand who their exact market is. Sales often have nothing to do with the product and more so with the particular physician or hospital and how they practice healthcare. Carevoyance helps life science companies understand the practice of healthcare for every physician and facility in the United States and prioritize their sales outreach to those that are most pertinent to their device or product.

Similar to regular sales companies, life science organizations organize their sales by territory. Carevoyance helps life science organizations determine where their market is by using a territory alignment/management approach. GIS is critical to this. Data is collected from various sources including census records, employment data, federal agencies, HUD, physician specific data sources and many others. The data is significantly more meaningful when aggregated around geographic areas. “We marry GIS with healthcare analytics,” said Geyfman.

Healthcare accessibility in rural areas is an increasingly growing problem in the United States. Carevoyance is working hard to help life science companies understand where the healthcare shortages are, what type of care is lacking and where people are going if they do not have access to the care they need. Understanding the referral patterns of various facilities and physicians is crucial for life science companies. If primary care doctors do not know where to obtain specific treatments, the patient often won’t get the necessary care. Carevoyance plays a vital role in this by using data to help educate rural physicians about all treatment options available. They foster connections between primary care doctors and specialists.

Currently, Carevoyance is focused on navigating the highly regulated industry and adding value to the relationship between life science companies and physicians. Building tools to navigate this restrictive environment would be valuable to both physicians and life science companies. Geyfman envisions for the future that our healthcare system will move towards a more value based care arrangement, so that there is incentives for the life sciences company to provide the absolute best product and care. Geyfman believes this incentive will most probably be financial and that the entire system will focus mainly on patient outcomes. GIS will play a big role in this by helping to reduce disparities in healthcare provision.

To  learn more about Carevoyance and their services, click here.

Written by Danielle Bayer